NCT01561664
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +9 more
- Locations
-
- Montpellier University Hospital Montpellier, France
Clinical trial condition
Insulin Resistance
Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.
2,345 public trials
206 recruiting studies
Insulin Resistance trial results
NCT01726777
- Conditions
- Avitaminosis, Deficiency Diseases, Diabetes Mellitus, +11 more
- Locations
-
- University of Guelph Guelph, Ontario, Canada
- Glycemic Index Laboratories Toronto, Ontario, Canada
- Institut de recherches cliniques de Montréal Montreal, Quebec, Canada
NCT02549443
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
- Locations
-
- McGill University Health Center Montreal, Quebec, Canada
NCT02261168
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- Maastricht University Maastricht, Netherlands
NCT01766570
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Diabetes, +7 more
- Locations
-
- Institute of Nutraceuticals and Functional Foods (INAF), Laval University Québec, Quebec, Canada
NCT02233283
- Conditions
- Female Reproductive System Disorder, Glucose Metabolism Disorders, Hyperinsulinism, +3 more
- Locations
-
- Clinical Research Center, University Hospital Lausanne, Canton of Vaud, Switzerland
NCT00542633
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
- Locations
-
Not specified
NCT01992783
- Conditions
- Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +9 more
- Locations
-
- Urmia, Azerbaijan-gharbi, Iran
NCT02526615
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +7 more
- Locations
-
- Turku PET Centre Turku, Finland
- Turku university hospital, PET center Turku, Finland
- Turku PET Centre (Turku University Hospital) Turku, Finland
Completed
Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects
NCT01631864
- Conditions
- Body Weight, Cardiovascular Diseases, Concurrent Obesity, +13 more
- Locations
-
- Novartis Investigative Site Hanover, Germany
- Novartis Investigative Site Neuss, Germany
- Novartis Investigative Site Maastricht, Netherlands